Washington, DC 20006-5349
HELPLINE
SAVE THE DATE
June 23-25, 2011 in Washington, DC. For more information visit curemeso.org/symposium. Stay tuned…
The Mesothelioma Applied Research Foundation is excited to announce its latest research grant recipients, awarding a total of $300,000. This brings the Foundation’s total funding
At the Mesothelioma Applied Research Foundation, we are guided by the three core pillars that define our purpose: funding groundbreaking research, providing essential treatment support
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
